Which of the following is NOT a factor to consider when converting IV medications to the enteral route?

• A. Color of the medication
• B. Tube size
• C. Distal tube tip placement
• D. Medication site of absorption

Answer: (A)

When converting IV medications to the enteral route, you must consider how the drug will dissolve and be absorbed in the GI tract and how the feeding tube’s setup affects delivery. The color of the medication doesn’t influence these factors; it has no bearing on dissolution, stability, absorption, or tube administration.

Tube size matters because it can limit whether the drug can be delivered as a slurry or crushed form without clogging the tube, and it affects dose accuracy and flow through the tube. Distal tube tip placement is relevant because absorption can vary by GI region; if the tube ends beyond the stomach, drugs that are best absorbed in the stomach may have reduced bioavailability. The medication site of absorption is key because drugs have preferred absorption sites, and delivering them to the wrong region can change how much of the drug is absorbed.

So, color isn’t a factor in the conversion, while tube size, distal tip placement, and the drug’s absorption site all influence the feasibility and effectiveness of enteral administration.